Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis-Reference-Cited by-同舟云学术

Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis

Published:2015-04 Issue:2 Volume:64 Page:285-294
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Habibi Mehri,Asadi Karam Mohammad Reza,Shokrgozar Mohammad Ali,Oloomi Mana,Jafari Anis,Bouzari Saeid

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference49 articles.

1. Mucosal immunization with iron receptor antigens protects against urinary tract infection;Alteri;PLoS Pathog.,2009

2. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum;Arakawa;Infect. Immun.,2005

3. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis;Armbruster;Nat. Rev. Microbiol.,2012

4. Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran;Asadi;Iran J. Microbiol.,2012

5. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice;Asadi Karam;Vaccine,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UNAM-HIMFG Bacterial Lysate Activates the Immune Response and Inhibits Colonization of Bladder of Balb/c Mice Infected with the Uropathogenic CFT073 Escherichia coli Strain;International Journal of Molecular Sciences;2024-09-12

2. Structure-Based Design of a Highly Immunogenic, Conformationally Stabilized FimH Antigen for a Urinary Tract Infection Vaccine;2024-06-10

3. New Strategies for the Prevention of Urinary Tract Infections by Uropathogenic Escherichia coli;Urinary Tract Infections - New Insights;2023-11-02

4. Development of Nasal Vaccines and the Associated Challenges;Pharmaceutics;2022-09-20

5. Secretory System Components as Potential Prophylactic Targets for Bacterial Pathogens;Biomolecules;2021-06-15